Address
Email address
https://jmolner.comThe J. Molner Company | Get Chemistry Done! | Analytical ChemsitryAmplify your generic drug pipeline with the J. Molner Company | Contract injectable development for the US, Canada, and Europe | Analytical Chemistry Services | Commerical and R&D stability services with our Nordic Stability Service team.
Name
J.Molner AS
Registry code
16579077
Type
AS - Joint Stock Company
Status
Registered
Foundation date
22.09.2022 (2)
Financial year
01.01-31.12
Capital
1 686 001.00 €
Activity
70221 - Business and other management consultancy activities
617 563 €
-30 203 €
-5%
52 €
(estimate is approximate)
263 169 €
27
Submitted
No tax arrears
-11%
-1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Jason Michael Atticus Grenfell-Gardner 09.10.1974 (50) | - | Board member | - | Founder |
| Karita Sall 08.11.1974 (50) | - | - | - | Board member |
| Martin Louis Wilson 08.11.1976 (48) | - | - | - | Board member |
| Yoann John Ricau 01.07.1975 (49) | - | - | - | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| The J. Molner Company OÜ 16049586 | 100% - 2 500.00 EUR | - | - |
| 2022 25.04.2023 | 2023 27.06.2024 | |
|---|---|---|
| Total Revenue | - | 617 563 € |
| Net profit (loss) for the period | -143 268 € | -30 203 € |
| Profit Margin | - | -5% |
| Current Assets | 644 534 € | 481 094 € |
| Fixed Assets | 1 600 000 € | 2 649 567 € |
| Total Assets | 2 244 534 € | 4 014 371 € |
| Current Liabilities | 89 474 € | 956 322 € |
| Non Current Liabilities | - | 1 911 170 € |
| Total Liabilities | - | 2 867 492 € |
| Share Capital | 1 686 001 € | 1 686 001 € |
| Equity | 2 155 060 € | 263 169 € |
| Employees | 0 | 27 |
